Search results
Results from the WOW.Com Content Network
e. Benzodiazepine withdrawal syndrome (BZD withdrawal) is the cluster of signs and symptoms that may emerge when a person who has been taking benzodiazepines as prescribed develops a physical dependence on them and then reduces the dose or stops taking them without a safe taper schedule.
Specialty. Psychiatry. Drug withdrawal, drug withdrawal syndrome, or substance withdrawal syndrome, [1] is the group of symptoms that occur upon the abrupt discontinuation or decrease in the intake of pharmaceutical or recreational drugs. In order for the symptoms of withdrawal to occur, one must have first developed a form of drug dependence.
Symptoms. Effects of long-term benzodiazepine use may include disinhibition, impaired concentration and memory, depression, [19][20] as well as sexual dysfunction. [6][21] The long-term effects of benzodiazepines may differ from the adverse effects seen after acute administration of benzodiazepines. [22] An analysis of cancer patients found ...
Many antidepressants can cause side effects, including nausea, digestive issues, headaches and difficulty sleeping. Though many side effects are common across antidepressants, the likelihood and ...
t. e. Physical dependence is a physical condition caused by chronic use of a tolerance -forming drug, in which abrupt or gradual drug withdrawal causes unpleasant physical symptoms. [4][5] Physical dependence can develop from low-dose therapeutic use of certain medications such as benzodiazepines, opioids, stimulants, antiepileptics and ...
[9] [10] Phentermine was withdrawn from the market in the United Kingdom in 2000, while the combination medication fen-phen, of which it was a part, was withdrawn from the market in 1997 due to side effects [11] of fenfluramine which caused increased levels of circulating serotonin which stimulated serotonin receptors on heart valves and thus ...
Vasculitis [3] Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [3][5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [2]
Image credits: lottiemossxo She explained: “It was from a doctor, but it wasn’t like you go into a doctor’s office and he prescribes it for you, takes your blood pressure, and takes tests ...